U.S. pharmaceutical company Johnson & Johnson (J&J) announced Tuesday it is suing the Department of Health and Human Services (HHS) over Medicare Drug Price Negotiation Program, becoming the latest of several organizations challenging the provision established by the Inflation Reduction Act. J&J joins fellow pharmaceutical companies Merck & Co., Bristol Myers Squibb as well as ...

It has become as familiar a sight in Washington as the cherry blossoms in spring: lobbyists from the nation’s hospitals descending on the Capitol to ask lawmakers to postpone billions in Medicaid funding cuts prescribed by the Affordable Care Act — cuts industry leaders agreed to years ago.

Republican members of California’s congressional delegation, this week sent a letter to Gov. Gavin Newsom, urging him to end the state tax on health savings accounts. Dubbed HSAs, these accounts allow someone to set aside money on a pre-tax basis to pay for qualified medical expenses.

The new regulations, which still need to go through a public comment period, would require insurers to study whether their customers have equal access to medical and mental health benefits and to take remedial action, if necessary.

As the industry gears up for open enrollment to begin this fall, a new report offers a look into the major factors that could impact premium changes in the individual and small group markets. The top issues to watch over the next several months include ongoing inflation, the end of the COVID-19 public health emergency ...

Inflation may be cooling, but high medical costs could still make consumers pay more for Affordable Care Act health insurance in 2024.